| Ytd | 46.90% | |
| 1y | 224.42% |
| Open | 150.94 | Prev Close | 152.29 | Low | 147.65 | High | 152.19 | Mkt Cap | 20.19B |
| Vol | 273.92K | Avg Vol | 2.66M | EPS | -2.58 | P/E | -59.03 | Forward P/E | -336.74 |
| Beta | 1.59 | Short Ratio | 3.88 | Inst. Own | 106.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-30 | 50-d Avg | 133.76 | 200-d Avg | 103.87 | 1yr Est | 157.13 |
Amova Asset Management Americas Inc. trimmed its position in shares of Guardant Health, Inc. (NASDAQ
Guggenheim analyst Subbu Nambi maintains Guardant Health (NASDAQ:GH) with a Buy and raises the pr
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Gr
Canaccord Genuity analyst Kyle Mikson maintains Guardant Health (NASDAQ:GH) with a Buy and raises
ISCG offers lower fees and broader diversification, while RZG's portfolio strategy has outperformed
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
Guardant Health stock jumped Thursday after key competitor, Freenome, unveiled study results for its
Morgan Stanley analyst Shannon O'Callaghan maintains Guardant Health (NASDAQ:GH) with a Overw
Citigroup analyst Patrick Donnelly maintains Guardant Health (NASDAQ:GH) with a Buy and raises th
ISCB offers ultra-low costs and 1,500+ holdings for diversification, while BBSC concentrates on fewe
Evercore ISI Group analyst Vijay Kumar maintains Guardant Health (NASDAQ:GH) with a Outperform an
B of A Securities analyst Michael Ryskin maintains Guardant Health (NASDAQ:GH) with a Buy and rai
Bernstein analyst Eve Burstein maintains Guardant Health (NASDAQ:GH) with a Outperform and raises
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
BTIG analyst Mark Massaro maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price t
Explore how portfolio size and sector exposure differ between these two small-cap ETFs, each offerin
Guggenheim analyst Subbu Nambi maintains Guardant Health (NASDAQ:GH) with a Buy and raises the pr
Bernstein analyst Eve Burstein reinstates Guardant Health (NASDAQ:GH) with a Outperform and annou
Barclays analyst Luke Sergott maintains Guardant Health (NASDAQ:GH) with a Overweight and raises
TD Cowen analysts estimate that the total addressable market for longevity healthcare exceeds $250 b
Not intended for distribution to U.S. newswire services or for dissemination in the U.S. Red Deer, A
Red Deer, Alberta--(Newsfile Corp. - June 12, 2026) - Gamehost Inc. (TSX: GH) ("Gamehost") announced
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
This biotech has a one-of-a-kind colon cancer blood test. Shares broke out of a base on recent news.
Wall Street analysts change ratings for top stocks: CRWD price target raised, FULC target lowered, H
Pre-Market Stock Futures: Futures are trading lower on Tuesday, but the technology tsunami continued
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the compan
PALO ALTO, Calif.--(BUSINESS WIRE)---- $GH--Guardant Health, Inc. (Nasdaq: GH), a leading precision
Guardant Health stock spiked Wednesday after the American Cancer Society recommended its blood test
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its FDA-app
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology
Quantum computing, AI and semiconductor-linked stocks dominated last week's large-cap gainers as
The U.S. Food and Drug Administration (FDA) on Wednesday approved Guardant Health Inc.'s (NASDAQ:GH)
FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
Gainers Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, l
On Friday, 1043 companies hit new 52-week lows.